181 related articles for article (PubMed ID: 2642538)
1. Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis.
Goldhirsch A; Gelber RD; Simes RJ; Glasziou P; Coates AS
J Clin Oncol; 1989 Jan; 7(1):36-44. PubMed ID: 2642538
[TBL] [Abstract][Full Text] [Related]
2. A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.
Gelber RD; Goldhirsch A
J Clin Oncol; 1986 Dec; 4(12):1772-9. PubMed ID: 3783203
[TBL] [Abstract][Full Text] [Related]
3. Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group.
Gelber RD; Goldhirsch A; Cavalli F
Ann Intern Med; 1991 Apr; 114(8):621-8. PubMed ID: 2003707
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.
Gelber RD; Cole BF; Goldhirsch A; Rose C; Fisher B; Osborne CK; Boccardo F; Gray R; Gordon NH; Bengtsson NO; Sevelda P
Lancet; 1996 Apr; 347(9008):1066-71. PubMed ID: 8602056
[TBL] [Abstract][Full Text] [Related]
5. Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis.
Cole BF; Gelber RD; Gelber S; Coates AS; Goldhirsch A
Lancet; 2001 Jul; 358(9278):277-86. PubMed ID: 11498214
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival.
Gelber RD; Cole BF; Goldhirsch A; Bonadonna G; Howell A; McArdle CS; Mouridsen HT; Rubens RD; Welvaart K
Cancer J Sci Am; 1995; 1(2):114-21. PubMed ID: 9166464
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant cyclophosphamide, methotrexate and fluorouracil for node-positive breast cancer: a lifetime cost-utility analysis based on a modified Q-TWIST method.
Trippoli S; Becagli P; Messori A
Eur J Clin Pharmacol; 1997; 53(3-4):281-2. PubMed ID: 9476047
[TBL] [Abstract][Full Text] [Related]
8. Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer.
Corey-Lisle PK; Peck R; Mukhopadhyay P; Orsini L; Safikhani S; Bell JA; Hortobagyi G; Roche H; Conte P; Revicki DA
Cancer; 2012 Jan; 118(2):461-8. PubMed ID: 21598243
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
Goldhirsch A; Gelber R
NCI Monogr; 1986; (1):55-70. PubMed ID: 3774016
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.
Powles TJ; Hickish TF; Makris A; Ashley SE; O'Brien ME; Tidy VA; Casey S; Nash AG; Sacks N; Cosgrove D
J Clin Oncol; 1995 Mar; 13(3):547-52. PubMed ID: 7884414
[TBL] [Abstract][Full Text] [Related]
11. Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinib.
Sherrill B; Sherif B; Amonkar MM; Maltzman J; O'Rourke L; Johnston S
Curr Med Res Opin; 2011 Dec; 27(12):2245-52. PubMed ID: 21992075
[TBL] [Abstract][Full Text] [Related]
12. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
Jahanzeb M
Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
[TBL] [Abstract][Full Text] [Related]
13. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
Hillner BE
Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
[TBL] [Abstract][Full Text] [Related]
14. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy.
Griem KL; Henderson IC; Gelman R; Ascoli D; Silver B; Recht A; Goodman RL; Hellman S; Harris JR
J Clin Oncol; 1987 Oct; 5(10):1546-55. PubMed ID: 3309196
[TBL] [Abstract][Full Text] [Related]
15. A quality-adjusted survival meta-analysis of adjuvant chemotherapy for premenopausal breast cancer. International Breast Cancer Study Group.
Cole BF; Gelber RD; Goldhirsch A
Stat Med; 1995 Aug; 14(16):1771-84. PubMed ID: 7481209
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy in early breast cancer.
Ejlertsen B
Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.
Crivellari D; Price K; Gelber RD; Castiglione-Gertsch M; Rudenstam CM; Lindtner J; Fey MF; Senn HJ; Coates AS; Collins J; Goldhirsch A;
J Clin Oncol; 2003 Dec; 21(24):4517-23. PubMed ID: 14673038
[TBL] [Abstract][Full Text] [Related]
18. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.
Crivellari D; Bonetti M; Castiglione-Gertsch M; Gelber RD; Rudenstam CM; Thürlimann B; Price KN; Coates AS; Hürny C; Bernhard J; Lindtner J; Collins J; Senn HJ; Cavalli F; Forbes J; Gudgeon A; Simoncini E; Cortes-Funes H; Veronesi A; Fey M; Goldhirsch A
J Clin Oncol; 2000 Apr; 18(7):1412-22. PubMed ID: 10735888
[TBL] [Abstract][Full Text] [Related]
19. Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
Ludwig Breast Cancer Study Group
Lancet; 1984 Jun; 1(8389):1256-60. PubMed ID: 6144974
[TBL] [Abstract][Full Text] [Related]
20. Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study.
Cole BF; Gelber RD; Kirkwood JM; Goldhirsch A; Barylak E; Borden E
J Clin Oncol; 1996 Oct; 14(10):2666-73. PubMed ID: 8874325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
